Ocular surface disease among glaucoma patients in Ibadan, South-West Nigeria

Authors

  • Dr.Sarimiye T.F Department of Ophthalmology, University College Hospital, Ibadan; Ancilla Catholic Hospital Eye Centre, Lagos, Nigeria https://orcid.org/0000-0001-7103-3975
  • Fasina O. 2Department of Ophthalmology, University College Hospital, Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Ashaye A. Department of Ophthalmology, University College Hospital, Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Bekibele C. Department of Ophthalmology, University College Hospital, Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Olawoye O. Department of Ophthalmology, University College Hospital, Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria

DOI:

https://doi.org/10.64666/joecsa.2015.135

Keywords:

Benzalkonium chloride, Glaucoma, Ibadan, Ocular surface disease

Abstract

Objective: To study the frequency and severity of ocular surface disease among glaucoma patients attending the Eye Clinic of the University College Hospital, Ibadan, Nigeria.
Methods: A hospital-based, cross sectional study was carried out at the Eye Clinic of the University College Hospital, Ibadan. After a detailed ocular examination, each respondent completed an Ocular Surface Disease Index (OSDI) questionnaire and performed central visual field assessment. Participants were analyzed for theeffect of anti-glaucoma topical medications (all BAK-preserved) and glaucoma severity on ocular surface disease.
Results: A total of 122 consecutive glaucoma patients were studied. Males accounted for 45.1%. Increasing daily drops of anti-glaucoma medication was significantly associated with increasing side effects such as redness, stinging and peppery sensations (p < 0.01). Eighty four patients representing 68.9% had some form of OSD using the OSDI score. The OSDI scores and the number of patients with OSD significantly increased with increasing glaucoma severity (p < 0.01).
Conclusion: Ocular surface disease was found to be associated with glaucoma severity and use of BAK-preserved topical anti-glaucoma medications.

Downloads

Published

2015-07-31

How to Cite

T.F, S., O., F., A., A., C., B., & O., O. (2015). Ocular surface disease among glaucoma patients in Ibadan, South-West Nigeria. Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA), 19(01). https://doi.org/10.64666/joecsa.2015.135

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.